Publication
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.
Aruj Dhyani, Nuray Tezcan, Joanne F Chou, Zeynep Tarcan, Rohit Thummalapalli, Fatema Nagib, Orla M Fitzpatrick, Darren Cowzer, Danny N Khalil, Wungki Park, Lily V Saadat, Kevin Soares, Alice Wei, William Jarnagin, Nikolaus Schultz, Joseph P Erinjeri, Mark Dunphy, David Solit, Walid Chatila, Eileen M O'Reilly, Ghassan K Abou-Alfa, Marinela Capanu, Olca Basturk, James J Harding
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Data on antibody-drug conjugates (ADCs) target expression prevalence, intertumoral heterogeneity, genomic concordance, and its effect on clinical outcomes is limited in biliary tract cancers (BTC). METHODS: Resected primary BTC specimens, and when available, matched metastatic samples…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT01775072registry_reference1.00
Registered trialsNCT01775072
Curated evidence
Evidence citing this paper (0)
Data not yet available